Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Sells $74,489.82 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III sold 1,257 shares of the firm’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $59.26, for a total value of $74,489.82. Following the transaction, the chief financial officer now owns 21,358 shares of the company’s stock, valued at $1,265,675.08. This trade represents a 5.56 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Kewaunee Scientific Stock Down 4.4 %

KEQU stock traded down $2.52 during midday trading on Monday, hitting $55.21. The company’s stock had a trading volume of 13,280 shares, compared to its average volume of 29,773. The firm has a 50-day simple moving average of $48.37 and a 200-day simple moving average of $45.02. The firm has a market capitalization of $158.56 million, a P/E ratio of 8.75 and a beta of 0.72. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48. Kewaunee Scientific Co. has a 52-week low of $27.00 and a 52-week high of $67.20.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. JPMorgan Chase & Co. increased its holdings in Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after purchasing an additional 900 shares during the period. Geode Capital Management LLC grew its position in shares of Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after buying an additional 1,941 shares in the last quarter. Ritholtz Wealth Management increased its stake in shares of Kewaunee Scientific by 24.6% during the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after buying an additional 2,156 shares during the period. Barclays PLC acquired a new stake in Kewaunee Scientific in the third quarter valued at approximately $121,000. Finally, Heron Bay Capital Management purchased a new position in Kewaunee Scientific in the second quarter worth approximately $252,000. 32.69% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.